Monthly Archives: March 2013

The latest in DME: an umbrella

When my wife moved to the States from Singapore, she was amazed to find that the umbrellas sold did not list their UV protection. Singapore is 137 km or 85 miles from the equator, and light skin is valued in Chinese culture. So protection from the aging and darkening effect of the sun’s rays has strong cultural underpinnings–unlike the US where there seems to be a tanning salon in every strip mall.

Normally we don’t think of an umbrella as DME (Durable Medical Equipment). However, if DME is home medical equipment you need for your health, then using an umbrella to prevent melanoma seems to qualify. As reported in JAMA Dermatology The researchers Josette R. McMichael, MD, Emir Veledar, PhD, and Suephy C. Chen, MD, MS of Emory University performed a simple, but well-designed experiment: they invited friends to join them in a parking lot, took 3 ultra-violet radiation (UVR) readings, and then opened umbrellas the friends had brought, taking two UVR readings, 1 cm from the individual, and 1 cm from the edge of the umbrella as shown:

Umbrella_uvr_measurement_20130304

There was wide variety in protection among the 22 umbrellas tested, ranging from a white totes® (77%) to a silver Coolibar® (99%). Fourteen were black in color.

Some of the numbers: Umbrella_findings_20130314

As is apparent in the account, the two readings (close and far) were highly correlated. The following scatterplot shows that as the values of each of the two readings are on the axes. The lowest reading shows the greatest protection, so umbrella 6 is the Coolibar®.

Umbrella_uvr_emory_20130304

As the earth warms, we can expect disturbances in the atmosphere that increase our exposure to UVR. Borrowing the style of the 19th century, carrying umbrellas, especially those designed to screen UVR, may be the best we can do.

How do we know?

In healthcare, or anything, that is an important question. It comes up in almost every healthcare encounter.

If the number of variables and their combinations were not so huge, it would be an easier question to answer.

We have individual genomes with their own proclivities. We have a dozen different prescription drugs or classes of drugs for the same condition. Then, we also have endoscopic and surgical interventions as well as medical devices, sometimes all for the same condition.

Millennia ago, the answer was easy: ask the shaman. The shaman was a religious leader with access to all hidden knowledge. In the West the first physicians were in Egypt and Babylonia, but still with heavy spiritual overtones. Later medicine seems to have split definitively from religion during the classical Graeco-Roman period, with physicians such as Hippocrates and Galen.

Knowledge began with spirit, continued with logic from the classical period to the medieval, and gave way to empirical methods in the Renaissance, formalized in the science of the modern period.

How we know something is the scope of the epistemology, a branch of philosophy. So, why am I waxing philosophical? Two events within the last month.

First, I went to my primary care physician for a preventive checkup. In discussing my medications to lower cholesterol, and I take more than one, he pointed out that studies had shown that one did not lower LDL and that another did not decrease mortality by raising HDL. And, we discussed our differing views of the matter.

Second, I read a blog discussion today about anti-depressants. A polymath named Irving Kirsch is a recognized expert on the placebo effect and questions the efficacy of antidepressants, most notably in a 2009 book The Emperor’s New Drugs.

During the discussion the name Karl Popper was mentioned. Popper was a 20th century philosopher credited with the concept of “falsification.” In the simplest terms, and not being a philosopher, I may distort his views, propositions cannot be established but only be proved false, or fail to be proved false. Furthermore, to be scientific a proposition must be falsifiable, so saying there is or is not a Deity is not a falsifiable proposition.

Let’s get back to healthcare: if I say that a drug for hypercholesteremia or for depression is no different than a placebo, then it is falsifiable. I can gather data and compare the effect of the medicine to the effect of a placebo. If they diverge by a sufficient amount statistically, then the idea that there is no difference has been falsified.

Even so, questions can always be posed about the methodology of any study, and the ensuing debate begins to resemble the medieval religious debates we thought we left behind.

Furthermore, not every variable that can cloud a conclusion can be eliminated. Two drugs may have negligible effects alone but work powerfully in tandem. A drug that works on one individual may not work on another. A drug may not work on 99 individuals and still be valuable for number 100.

Finally, even if every question of efficacy was answered, the questions of values remain. Those questions are most visible in the public arena with respect to abortion, birth control, end-of-life decisions, and the availability of certain drugs. Less visible but just as important is the following scenario: a patient has a painful condition for which there is an effective intervention. Unfortunately the odds are 60% complete cure, 20% no effect, 15% debilitating injury that is worse than the initial condition, and 5% death. Even if these percentages are accurate and cut in stone with no chance of distinguishing a priori in which basket a given patient will fall, then the clinician can recommend but not decide. The 20% aggregate possibility of a worse outcome than doing nothing has to be left to the patient.

We can produce rules for tests to be made, pharmaceuticals and other interventions to be offered, but for the moment the number of possible interventions and the nearly infinite possibilities of human diversity mean our rules will be imperfect, no matter how well researched, studied, and reviewed.

Having read a bit about Kirsch, I doubt if he is right, but even if he is right, the 25% impact of pharmaceuticals on depression may make them worthwhile even if most of their impact is placebo. I am still taking the same cholesterol medications as I have found through experimentation that removing one raises my cholesterol and retaking it lowers it again, and I am alive 20 plus years beyond the life span of my father and his father.

That is how it should be. The important decisions in life (where to live, who to live with, where to work) are all made based upon imperfect information. So are our health care decisions, but we make them as patients and clinicians with the best knowledge available and hope to look back upon our having been correct.

What’s a woman to do? Or a man? Dairy and weight and bones and stuff.

In many ways women’s health is more challenging than men’s.

Women over age 50 are much more likely to get breast cancer, or its precursors, such as fibrocystic breast disease.

Women get cervical and ovarian cancer–men don’t need pap smears or the equivalent.

Women are five times more prone to osteoporosis.

Many medical studies have disproportionately targeted men, although that is changing.

But let’s just consider osteoporosis for a moment. Some risk factors are:

  1. Unchangeable
    • Sex
    • Age
    • Race
    • Family History
    • Frame Size
  2. Hormone Levels
    • Sex Hormones
    • Thyroid
    • Other Glands
  3. Dietary
    • Low Calcium Intake
    • Eating Disorders
    • Weight Loss Surgery
  4. Steroid Prescriptions and Others
  5. Lifestyle
    • Sedentary Lifestyle
    • Excessive Alcohol Consumption
    • Tobacco Use
  6. Too little estrogen

This is but one ailment, but threading the needle is difficult. Consider that sedentary lifestyle and inadequate weight are opposites. If someone exercises and loses weight, the risk is increased. If someone does not exercise, the risk is increased. And the task is even more complicated. A recent study found that consumption of high-fat dairy is associated with increased mortality from breast cancer–so your doctor will probably tell you to stick to low-fat dairy to get additional calcium–be sure to ask.

Very often we hear that someone fell and broke their hip; less often we realize that someone’s hip broke, and they fell.

The International Osteoporosis Foundation estimates that 1 in 3 women and 1 in 5 men will experience a fracture from osteoporosis.

Osteoporosis affects more than 10 million Americans, accounting for 1.5 million fractures annually.

Bad News for Boomers: Our Parents Were Healthier

As Americans we believe in progress, in a better tomorrow, sometimes with a bump in the road or a hiccough, but always a better tomorrow.

The data are in (March 4,2013 edition of JAMA Internal Medicine), and it ain’t happening for boomers. Blood pressure, cholesterol, diabetes, and obesity–all greater than the previous generation.

Boomer_Parent_Comparison_JAMAinternalmed_20130304
Source: The Status of Baby Boomers’ Health in the United States The Healthiest Generation?
Dana E. King, MD, MS; Eric Matheson, MD, MS; Svetlana Chirina, MPH; Anoop Shankar, MD, PhD, MPH; Jordan Broman-Fulks
JAMA Intern Med. 2013;173(5):385-386

Although longevity has risen during the twenty-year gap between the two groups, every other indicator of health, except smoking, has become less favorable. And the pattern is clear.

At the top of the following chart are general measures of health. Then, we can see that lifestyle factors have declined leading to the trends in the last section: declining indicators of cardiovascular health.

We can’t choose to be healthy or not: what we can do is make healthy choices by changing the lifestyle factors.

We are choosing illness at great expense to ourselves, both financially and in quality of life, while continuing to endure longer and sicker lives instead of enjoying healthier lives.

Boomer_Parent_Extract_Comparison

Salt: Connecting the Dots

Some number of millenia ago our evolutionary forebears crawled out of the sea, carrying its salt flowing through their veins to ours. In the right amount, salt is not only good for us but essential to life.

That is not the same, however, as dumping salt on our food before tasting it or eating processed dinners, from the supermarket or from the nearest fast food franchise.

Most of us have long known that salt increases hypertension among salt-sensitive individuals.

Two sets of studies have come out, one widely publicized, the other well below the radar, that add concerns about excess salt consumption.

Researchers publishing in a recent issue of Nature have linked salt consumption to auto-immune disorders such as multiple sclerosis, psoriasis, ankylosing spondylitis, and rheumatoid arthritis. Unless you have a $200 annual subscription to Nature, you may wish to google “salt autoimmune” to read descriptions of the studies. Or, you may wish to simply click on these links to Medical News Today or The Huffington Post.

So, what are the dots to be connected? That’s where the second study comes in, the one with little publicity.

A presentation at the 2013 American Academy of Dermatology annual meeting in March found that individuals with psoriasis were more likely to have metabolic syndrome. They found that 30 percent of the psoriasis children had metabolic syndrome symptoms compared to the non-psoriasis group. There were not significant differences in Body-Mass Index (BMI), c-reactive protein, or endothelial cells

A 2012 study in South India found a higher incidence of metabolic syndrome among those with psoriasis. In this case:

Patients were diagnosed with MetS for having three or more South Asian Modified National Cholesterol Education Program Adult Treatment Panel III criteria: abdominal obesity (waist circumference ≥90 cm for men, ≥80 cm for women); blood pressure, >130/85 mm Hg; fasting blood glucose, ≥100 mg/dL; hypertriglyceridemia, >150 mg/dL; or low HDL (<40 mg/dL for men, <50 mg/dL for women).

Calcium: Friend or foe? Part II

Last time we looked at calcium supplements and cardiovascular risk. The indicators are strong that men should not be taking calcium supplements in the absence of a very clear, unambiguous reason to do so. Women at risk for osteoporosis, for example, need to discuss the relative risks and benefits with their physician. No treatment is without potential risks, so we need to make decisions based on likely outcomes and known risks.

Susanna C. Larsson PhD puts the issue of calcium in perspective:

Larsson_JAMA_Calcium_2013

In addition to the cardiovascular risks we have considered, there are elevated risks of kidney stones (renal calculi). Calcium is intimately related to the development of kidney stones, also called “calcium stones.

The U.S.Preventive Services Task Force has issued recommendations.

Annals of Medicine Calcium 2013

Here is what those recommendations ( I Statement and Grade: D) mean:

UPSTF grades

The best, meaning safest, sources of calcium are not supplements but diet. The Office of Dietary Supplements at NIH has issued a helpful Calcium Fact Sheet/a>

The recommended daily allowances for calcium are:

CalciumRDAs

And some of the best sources to attain that level of daily calcium consumption are:
NIHCalciumsources

Calcium: Friend or foe? Part I

As I approached a certain age, my doctor said, “Oh, are you taking calcium supplements?” And, I asked him, “Isn’t arterial plaque calcified cholesterol? Is it really a good idea to flood my arteries with calcium?” He is a thoughtful person. “Maybe not,” he said, upon reflection.

The main therapeutic use of calcium supplements is to ward off osteoporosis. We are beginning to live longer than our bones were intended, and we are trying to avoid turning into boneless amoebae before we die. Knowing from childhood that “calcium builds strong bones,” we thought calcium supplements made perfect sense.

Calcium Source: news@Jama

I felt really validated when studies came out showing calcium to be a cardiac risk. The most recent was published online a month ago. The NIH AARP Diet and Health Study found a higher risk of cardiovascular events in men taking supplementary calcium. Why the risk did not appear to be elevated for women is a subject for further study.

Similar findings have been reported in the British Medical Journal: Heart and Education in Heart.
Calcium supplements: bad for the heart?
Heart 2012;98:12 895-896

As well as in other European studies:
2011_BMJ_Heart_Calcium